Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of fexofenadine 120mg BID
compared to placebo in the treatment of subjects with mild to moderate persistent asthma